Free pricing in Europe soon to be a thing of the past?
This article was originally published in Scrip
Just three European countries out of 27 surveyed have free pricing policies for pharmaceuticals, says a new report from the Pharmaceutical Pricing and Reimbursement Information (PPRI) project. The report also demonstrates that reference pricing is now the choice pricing system across Europe, a strong indication of the popularity of cost containment measures among health authorities.
You may also be interested in...
While information sharing is key to cross-country collaborations on access to medicines and can lead to major benefits, it is hard to sell to political leaders and the media, says a report from the World Health Organization’s regional office for Europe.
The European Commission says it will publish its review of the EU orphan drug legislation in the coming days.
The UK has formally withdrawn its ratification of the Unified Patent Court Agreement, adding to the uncertainty over its future.